Riverside-backed InVita Invests in STACS DNA
May 18, 2021
The Riverside Company has invested in STACS DNA as an add-on to its InVita Healthcare Technologies platform; InVita (backed by Riverside) will integrate STACS DNA's sample-tracking and lab management software into its suite for complex medical environments. STACS DNA, headquartered in Ottawa, Ontario, provides forensic and healthcare sample-tracking solutions used by customers such as the FBI, RCMP and Merck to improve laboratory workflows, compliance and patient safety.
- Targets
- STACS DNA
- Platforms
- InVita Healthcare Technologies
- Industry
- Software
- Location
- Ontario, Canada
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.